We are live on ! Find out more
LEGN icon

Legend Biotech

191 hedge funds and large institutions have $1.74B invested in Legend Biotech in 2026 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 49 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more capital inflows, than outflows

Capital inflows: $337M | Capital outflows: $187M

63% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 49

28% more call options, than puts

Call options by funds: $11.8M | Put options by funds: $9.22M

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

4.51% more ownership

Funds ownership: 47.44% → 51.94% (+4.5%)

5% less funds holding

Funds holding: 201 → 191 (-10)

20% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 41

Holders
191
Holders Change
-10
Holders Change %
-4.98%
% of All Funds
2.32%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.08%
New
33
Increased
80
Reduced
49
Closed
41
Calls
$11.8​M
Puts
$9.22​M
Net Calls
+$2.6​M
Net Calls Change
+$4.25​M

LEGN Hedge Fund Activity: Q1 2026 in Review

191 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q1 2026, worth a combined $1.74B — down 8.9% from $1.91B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of LEGN and 33 opened new positions — a net loss of 8 holders — while 49 trimmed existing stakes and 80 added.

The largest buyer was First Beijing Investment, opening a new position worth an estimated $43.8M. The largest seller was AllianceBernstein, exiting entirely with an estimated $33M sold.

  • 191 institutional investors held Legend Biotech (LEGN) as of Q1 2026, down from 201 in Q4 2025.
  • Funds reported $1.74B of Legend Biotech stock for Q1 2026, down 8.9% quarter-over-quarter.
  • 33 funds opened new Legend Biotech positions in Q1 2026 and 41 closed out, a net change of -8 holders.
  • The largest Legend Biotech buyer in Q1 2026 was First Beijing Investment, an estimated $43.8M added.
  • The largest Legend Biotech seller in Q1 2026 was AllianceBernstein, an estimated $33M sold.

Based on aggregated 13F filings for Q1 2026.